Table 2.
HR(95% CI) | P-value | |
---|---|---|
60-Day In-Hospital All-Cause Mortality | ||
Model 1 | 1.126 (1.090–1.164) | <0.001 |
Model 2 | 1.115 (1.093–1.093) | 0.001 |
Model 3 | 1.052 (1.022–1.083) | 0.001 |
60-Day In-Hospital Cardiovascular Mortality | ||
Model 1 | 1.125 (1.087–1.163) | <0.001 |
Model 2 | 1.063 (1.012–1.117) | 0.015 |
Model 3 | 1.064 (1.013–1.118) | 0.014 |
30-Day Readmission | ||
Model 1 | 1.108 (1.069–1.148) | <0.001 |
Model 2 | 1.064 (1.018–1.111) | 0.006 |
Model 3 | 1.061 (1.015–1.108) | 0.009 |
Model 1: Adjusted for age and gender.
Model 2: Adjusted for age, gender, BP at admission >140/90 mmHg, history of diabetes, history of atrial fibrillation, history of stroke, history of myocardial infarction, New York Heart Association (NYHA) class, left ventricular ejection fraction (LVEF), white blood cell count, triglyceride.
Model 3: Adjusted for age, gender, BP at admission >140/90 mmHg, history of diabetes, history of atrial fibrillation, history of stroke, history of myocardial infarction, NYHA class, LVEF, white blood cell count, triglyceride, use of digoxin, use of intravenous inotropes, use of beta-blocker, use of lipid-lowering agents.